Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at idasanutlin and cytarabine for acute myeloid leukaemia

Overview

Cancer types:

Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia

Status:

Closed

Phase:

Phase 3

Details

This trial is for people whose acute myeloid leukaemia (AML) has come back or continued to grow following their first or second treatment.

Recruitment start: 1 September 2016

Recruitment end: 10 January 2020

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Steve Knapper

Supported by

Roche

Last reviewed: 21 Jan 2020

CRUK internal database number: 14271

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.